<DOC>
	<DOCNO>NCT00760448</DOCNO>
	<brief_summary>This trial conduct UK . The aim clinical trial investigate lower blood sugar symptom experience hypoglycaemia</brief_summary>
	<brief_title>Comparison Insulin Detemir NPH With Respect Lowering Blood Sugar Symptoms Experienced Type 1 Diabetics During Hypoglycaemia</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Isophane insulin , beef</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Detemir</mesh_term>
	<mesh_term>Isophane Insulin , Human</mesh_term>
	<mesh_term>Insulin , Isophane</mesh_term>
	<criteria>Signed date informed consent obtain trialrelated activity . Type 1 diabetes Treatment insulin minimum three month Duration diabetes 12 month Body Mass Index ( BMI ) less 30 kg/m2 HbA1c equal great 10 % base analysis central laboratory Participation clinical trial involve investigational product within last three month Current treatment insulin daily dose 100 U Episode symptomatic hypoglycaemia , capillary plasma glucose value le 3.5 mmol/L past two week Hypoglycaemic unawareness severe autonomic neuropathy Current treatment drug know interfere glucose metabolism systemic corticosteroid , nonselective betablockers MAO inhibitor Current treatment oral antidiabetic drug Impaired hepatic function measure ALAT two time upper reference limit Impaired renal function measure creatinine 150 micromol/L ( 1.7 mg/dL ) Cardiac problem define decompensated heart failure ( NYHA class III IV ) time and/or angina pectoris and/or myocardial infarction within last 12 month Known suspect allergy trial product relate product Mental incapacity , unwillingness language barrier preclude adequate understanding cooperation Blood donation 500 mL within last three month Any condition Investigator and/or Sponsor feel would interfere study participation evaluation result Pregnancy intention become pregnant , breastfeed judge use inadequate contraceptive method . Adequate contraceptive method sterilisation , intrauterine device ( IUD ) , oral contraceptive consistent use barrier method Previous participation trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>